Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Orbital Diseases | 17 | 2023 | 181 | 8.300 |
Why?
|
Orbit | 24 | 2022 | 426 | 7.120 |
Why?
|
Eyelids | 15 | 2023 | 265 | 4.060 |
Why?
|
Eyelid Diseases | 10 | 2017 | 155 | 3.980 |
Why?
|
Graves Ophthalmopathy | 10 | 2023 | 117 | 3.750 |
Why?
|
Eyelid Neoplasms | 8 | 2019 | 94 | 3.420 |
Why?
|
Ophthalmologic Surgical Procedures | 11 | 2021 | 349 | 3.160 |
Why?
|
Orbital Fractures | 6 | 2020 | 110 | 2.810 |
Why?
|
Orbital Neoplasms | 9 | 2018 | 225 | 2.770 |
Why?
|
Orbital Cellulitis | 4 | 2023 | 33 | 2.510 |
Why?
|
Lacrimal Apparatus | 4 | 2023 | 225 | 2.440 |
Why?
|
Cysts | 7 | 2021 | 678 | 2.400 |
Why?
|
Blepharoptosis | 7 | 2024 | 143 | 2.380 |
Why?
|
Dacryocystitis | 4 | 2022 | 70 | 2.050 |
Why?
|
Nasolacrimal Duct | 5 | 2019 | 74 | 1.940 |
Why?
|
Conjunctival Diseases | 4 | 2020 | 122 | 1.750 |
Why?
|
Epidermal Cyst | 3 | 2017 | 62 | 1.650 |
Why?
|
Blepharoplasty | 3 | 2023 | 50 | 1.650 |
Why?
|
Temporal Arteries | 7 | 2015 | 128 | 1.580 |
Why?
|
Dacryocystorhinostomy | 6 | 2020 | 72 | 1.580 |
Why?
|
Oculomotor Muscles | 7 | 2023 | 371 | 1.500 |
Why?
|
Sinusitis | 4 | 2022 | 923 | 1.460 |
Why?
|
Enophthalmos | 5 | 2019 | 34 | 1.460 |
Why?
|
Lacrimal Apparatus Diseases | 4 | 2018 | 65 | 1.450 |
Why?
|
Conjunctiva | 5 | 2020 | 494 | 1.400 |
Why?
|
Cavernous Sinus | 2 | 2021 | 125 | 1.360 |
Why?
|
Eye Infections, Fungal | 3 | 2022 | 110 | 1.360 |
Why?
|
Decompression, Surgical | 7 | 2021 | 594 | 1.300 |
Why?
|
Keratins | 4 | 2017 | 515 | 1.180 |
Why?
|
Face | 5 | 2023 | 994 | 1.180 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 2 | 2017 | 44 | 1.160 |
Why?
|
Eye Foreign Bodies | 2 | 2020 | 55 | 1.120 |
Why?
|
Hair Diseases | 2 | 2017 | 74 | 1.110 |
Why?
|
Conjunctival Neoplasms | 2 | 2017 | 79 | 1.100 |
Why?
|
Emphysema | 2 | 2019 | 247 | 1.090 |
Why?
|
Lacrimal Duct Obstruction | 4 | 2020 | 48 | 1.080 |
Why?
|
Eye Injuries, Penetrating | 2 | 2020 | 115 | 1.030 |
Why?
|
Optic Nerve Diseases | 2 | 2022 | 327 | 0.970 |
Why?
|
Giant Cell Arteritis | 6 | 2015 | 292 | 0.960 |
Why?
|
Hematoma | 3 | 2020 | 758 | 0.960 |
Why?
|
Biopsy | 17 | 2020 | 6756 | 0.940 |
Why?
|
Orbital Implants | 3 | 2021 | 21 | 0.940 |
Why?
|
Eye Diseases | 3 | 2019 | 669 | 0.920 |
Why?
|
Ectropion | 2 | 2020 | 26 | 0.900 |
Why?
|
Photography | 2 | 2016 | 520 | 0.880 |
Why?
|
Choristoma | 2 | 2016 | 213 | 0.860 |
Why?
|
Facial Nerve Injuries | 2 | 2013 | 63 | 0.810 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 222 | 0.810 |
Why?
|
Anophthalmos | 2 | 2021 | 22 | 0.800 |
Why?
|
Cavernous Sinus Thrombosis | 1 | 2021 | 14 | 0.790 |
Why?
|
Neoplasms, Basal Cell | 1 | 2021 | 31 | 0.780 |
Why?
|
Entropion | 1 | 2020 | 10 | 0.780 |
Why?
|
Keratosis, Seborrheic | 1 | 2021 | 27 | 0.780 |
Why?
|
Dermoid Cyst | 1 | 2021 | 93 | 0.760 |
Why?
|
Mucocele | 1 | 2020 | 49 | 0.750 |
Why?
|
Eyelashes | 2 | 2017 | 16 | 0.730 |
Why?
|
Ophthalmology | 4 | 2017 | 508 | 0.730 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2021 | 103 | 0.720 |
Why?
|
Diagnosis, Differential | 17 | 2021 | 12959 | 0.710 |
Why?
|
Scleroderma, Localized | 2 | 2018 | 79 | 0.700 |
Why?
|
Blinking | 2 | 2020 | 138 | 0.700 |
Why?
|
Subcutaneous Emphysema | 1 | 2019 | 16 | 0.690 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2018 | 180 | 0.690 |
Why?
|
Skin Neoplasms | 5 | 2021 | 5686 | 0.690 |
Why?
|
Maxillary Fractures | 1 | 2019 | 20 | 0.680 |
Why?
|
Postoperative Complications | 9 | 2021 | 15295 | 0.670 |
Why?
|
Zygomatic Fractures | 1 | 2019 | 37 | 0.670 |
Why?
|
Hypesthesia | 2 | 2019 | 109 | 0.670 |
Why?
|
Injections | 1 | 2022 | 840 | 0.670 |
Why?
|
Limbus Corneae | 1 | 2021 | 144 | 0.670 |
Why?
|
Tomography, X-Ray Computed | 18 | 2021 | 20129 | 0.660 |
Why?
|
Trichiasis | 1 | 2018 | 5 | 0.660 |
Why?
|
Humans | 125 | 2024 | 744343 | 0.660 |
Why?
|
Botulinum Toxins, Type A | 1 | 2022 | 213 | 0.660 |
Why?
|
Diplopia | 6 | 2023 | 200 | 0.650 |
Why?
|
Facial Neoplasms | 1 | 2019 | 121 | 0.640 |
Why?
|
Acrylates | 1 | 2018 | 89 | 0.640 |
Why?
|
Ophthalmoplegia | 1 | 2019 | 166 | 0.630 |
Why?
|
Eye Injuries | 2 | 2019 | 245 | 0.630 |
Why?
|
Doxycycline | 1 | 2019 | 326 | 0.630 |
Why?
|
Granuloma, Foreign-Body | 1 | 2018 | 45 | 0.630 |
Why?
|
Frontal Bone | 1 | 2018 | 105 | 0.630 |
Why?
|
Surgery, Computer-Assisted | 2 | 2017 | 1018 | 0.620 |
Why?
|
Facial Nerve | 1 | 2020 | 271 | 0.610 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2017 | 40 | 0.610 |
Why?
|
Facial Dermatoses | 1 | 2018 | 87 | 0.610 |
Why?
|
Mucormycosis | 2 | 2015 | 97 | 0.610 |
Why?
|
Carcinoma, Basal Cell | 2 | 2021 | 545 | 0.600 |
Why?
|
Exophthalmos | 4 | 2023 | 97 | 0.600 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 445 | 0.570 |
Why?
|
Gelatin | 1 | 2018 | 225 | 0.570 |
Why?
|
Meningomyelocele | 1 | 2018 | 165 | 0.570 |
Why?
|
Biometric Identification | 1 | 2016 | 3 | 0.570 |
Why?
|
Hair Follicle | 2 | 2016 | 209 | 0.570 |
Why?
|
Lymphangioma | 2 | 2014 | 65 | 0.560 |
Why?
|
Endoscopy | 6 | 2019 | 1785 | 0.560 |
Why?
|
Exanthema | 1 | 2021 | 501 | 0.560 |
Why?
|
Cosmetic Techniques | 1 | 2018 | 135 | 0.550 |
Why?
|
Retrospective Studies | 37 | 2023 | 77449 | 0.550 |
Why?
|
Pigmentation | 1 | 2016 | 148 | 0.550 |
Why?
|
Aneurysm | 1 | 2019 | 339 | 0.550 |
Why?
|
Retinal Vein Occlusion | 1 | 2017 | 137 | 0.540 |
Why?
|
Glucocorticoids | 8 | 2020 | 2107 | 0.540 |
Why?
|
Melanosis | 1 | 2016 | 78 | 0.540 |
Why?
|
Hemostatics | 1 | 2018 | 229 | 0.540 |
Why?
|
Neuroma | 1 | 2016 | 103 | 0.520 |
Why?
|
Rhinoplasty | 1 | 2019 | 226 | 0.510 |
Why?
|
Human papillomavirus 16 | 1 | 2017 | 262 | 0.510 |
Why?
|
Blindness | 1 | 2019 | 617 | 0.510 |
Why?
|
Ophthalmic Artery | 1 | 2015 | 60 | 0.510 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2019 | 300 | 0.510 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2015 | 67 | 0.500 |
Why?
|
Elastic Tissue | 1 | 2014 | 65 | 0.500 |
Why?
|
Granuloma | 1 | 2017 | 319 | 0.500 |
Why?
|
Hyaluronic Acid | 1 | 2018 | 491 | 0.490 |
Why?
|
Chalazion | 1 | 2014 | 13 | 0.490 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 1519 | 0.490 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 234 | 0.490 |
Why?
|
Foreign Bodies | 1 | 2018 | 399 | 0.480 |
Why?
|
Sphenoid Bone | 1 | 2015 | 172 | 0.470 |
Why?
|
Waiting Lists | 1 | 2018 | 692 | 0.470 |
Why?
|
Corneal Diseases | 2 | 2019 | 636 | 0.460 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2016 | 245 | 0.460 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2014 | 109 | 0.460 |
Why?
|
Abscess | 3 | 2022 | 607 | 0.460 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2015 | 171 | 0.460 |
Why?
|
Aspergillosis | 1 | 2015 | 235 | 0.450 |
Why?
|
Eyebrows | 1 | 2013 | 28 | 0.450 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2015 | 118 | 0.450 |
Why?
|
Prosthesis Implantation | 2 | 2021 | 642 | 0.450 |
Why?
|
Ethmoid Bone | 1 | 2013 | 35 | 0.440 |
Why?
|
Middle Aged | 42 | 2023 | 213383 | 0.440 |
Why?
|
Nasal Bone | 1 | 2013 | 58 | 0.440 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2013 | 31 | 0.440 |
Why?
|
Intracranial Hypotension | 1 | 2013 | 41 | 0.440 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 882 | 0.440 |
Why?
|
Craniotomy | 2 | 2014 | 729 | 0.440 |
Why?
|
Pseudolymphoma | 1 | 2012 | 30 | 0.440 |
Why?
|
Hydrogels | 1 | 2018 | 724 | 0.430 |
Why?
|
Sella Turcica | 1 | 2013 | 119 | 0.430 |
Why?
|
Eye Neoplasms | 1 | 2014 | 313 | 0.430 |
Why?
|
Carcinoma, Lobular | 1 | 2017 | 484 | 0.430 |
Why?
|
Respiratory Mucosa | 1 | 2016 | 427 | 0.420 |
Why?
|
Hemangioma, Cavernous | 1 | 2013 | 110 | 0.420 |
Why?
|
Visual Field Tests | 2 | 2012 | 383 | 0.420 |
Why?
|
Male | 55 | 2023 | 350118 | 0.420 |
Why?
|
Skin Transplantation | 2 | 2015 | 1074 | 0.410 |
Why?
|
Cornea | 2 | 2019 | 1524 | 0.400 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2013 | 194 | 0.400 |
Why?
|
Skull Fractures | 1 | 2013 | 195 | 0.400 |
Why?
|
Surgery, Plastic | 1 | 2018 | 624 | 0.390 |
Why?
|
Adult | 37 | 2023 | 214055 | 0.380 |
Why?
|
Keratin-17 | 3 | 2016 | 26 | 0.380 |
Why?
|
Female | 52 | 2023 | 380194 | 0.380 |
Why?
|
Hemianopsia | 1 | 2012 | 122 | 0.370 |
Why?
|
Paranasal Sinuses | 1 | 2013 | 250 | 0.370 |
Why?
|
Anti-Bacterial Agents | 4 | 2023 | 7181 | 0.370 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1832 | 0.370 |
Why?
|
Aphasia | 1 | 2011 | 179 | 0.360 |
Why?
|
Visual Acuity | 7 | 2019 | 2530 | 0.350 |
Why?
|
Boronic Acids | 1 | 2014 | 965 | 0.350 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2017 | 1101 | 0.350 |
Why?
|
Light | 1 | 2016 | 1374 | 0.350 |
Why?
|
Hair | 1 | 2012 | 483 | 0.340 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1387 | 0.340 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 693 | 0.340 |
Why?
|
Vision, Low | 1 | 2011 | 168 | 0.340 |
Why?
|
Disease Management | 1 | 2020 | 2459 | 0.340 |
Why?
|
Program Evaluation | 1 | 2017 | 2488 | 0.330 |
Why?
|
Skull | 1 | 2013 | 813 | 0.320 |
Why?
|
Aged | 29 | 2023 | 163280 | 0.320 |
Why?
|
Pyrazines | 1 | 2014 | 1230 | 0.320 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 1504 | 0.310 |
Why?
|
Mucopolysaccharidosis II | 1 | 2007 | 27 | 0.300 |
Why?
|
Adipose Tissue | 1 | 2019 | 3279 | 0.300 |
Why?
|
Visual Fields | 2 | 2012 | 1047 | 0.300 |
Why?
|
Lymphoma | 1 | 2016 | 1877 | 0.300 |
Why?
|
Intraoperative Complications | 1 | 2014 | 1198 | 0.300 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 689 | 0.300 |
Why?
|
Aged, 80 and over | 16 | 2023 | 57776 | 0.290 |
Why?
|
Skin | 3 | 2016 | 4364 | 0.280 |
Why?
|
Societies, Medical | 2 | 2017 | 3743 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 14 | 2021 | 35421 | 0.270 |
Why?
|
Neoplasm Proteins | 3 | 2016 | 3703 | 0.270 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3176 | 0.270 |
Why?
|
Ultrasonography | 1 | 2019 | 5985 | 0.260 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13695 | 0.260 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2291 | 0.260 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1587 | 0.260 |
Why?
|
Keratin-7 | 2 | 2016 | 57 | 0.250 |
Why?
|
Software | 2 | 2016 | 4443 | 0.250 |
Why?
|
Skin Diseases | 1 | 2012 | 1065 | 0.240 |
Why?
|
Immunohistochemistry | 5 | 2016 | 11366 | 0.240 |
Why?
|
Nerve Regeneration | 2 | 2020 | 788 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4034 | 0.230 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 2957 | 0.230 |
Why?
|
Immunotherapy | 1 | 2019 | 4445 | 0.230 |
Why?
|
Philadelphia Chromosome | 1 | 2023 | 112 | 0.230 |
Why?
|
Syringoma | 1 | 2022 | 5 | 0.220 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11031 | 0.220 |
Why?
|
Shewanella | 1 | 2022 | 10 | 0.210 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39050 | 0.210 |
Why?
|
Staining and Labeling | 2 | 2018 | 1100 | 0.210 |
Why?
|
Neurology | 1 | 2010 | 763 | 0.210 |
Why?
|
Debridement | 2 | 2015 | 492 | 0.210 |
Why?
|
Fundus Oculi | 2 | 2017 | 473 | 0.200 |
Why?
|
Eye | 2 | 2023 | 729 | 0.200 |
Why?
|
Rejuvenation | 1 | 2022 | 91 | 0.200 |
Why?
|
Sweat Gland Neoplasms | 1 | 2022 | 108 | 0.190 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5137 | 0.190 |
Why?
|
Papilledema | 1 | 2022 | 118 | 0.190 |
Why?
|
Folliculitis | 1 | 2019 | 28 | 0.180 |
Why?
|
Optic Neuritis | 1 | 2022 | 166 | 0.180 |
Why?
|
Breast Neoplasms | 2 | 2017 | 20822 | 0.180 |
Why?
|
Ophthalmic Nerve | 1 | 2019 | 43 | 0.170 |
Why?
|
Adrenal Cortex Hormones | 2 | 2023 | 1855 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.170 |
Why?
|
Oculomotor Nerve | 1 | 2019 | 74 | 0.160 |
Why?
|
Fluorescein Angiography | 2 | 2017 | 940 | 0.160 |
Why?
|
Scalp | 1 | 2021 | 380 | 0.160 |
Why?
|
Injections, Intralesional | 2 | 2015 | 276 | 0.150 |
Why?
|
Nerve Transfer | 1 | 2019 | 120 | 0.150 |
Why?
|
Neurofibroma | 1 | 2018 | 106 | 0.150 |
Why?
|
Steroids | 1 | 2023 | 930 | 0.150 |
Why?
|
Internship and Residency | 1 | 2017 | 5788 | 0.150 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8642 | 0.150 |
Why?
|
Tick Infestations | 1 | 2016 | 10 | 0.140 |
Why?
|
Eye Infections, Parasitic | 1 | 2016 | 24 | 0.140 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5181 | 0.140 |
Why?
|
Orbital Myositis | 1 | 2016 | 20 | 0.140 |
Why?
|
Drainage | 1 | 2022 | 1142 | 0.140 |
Why?
|
Young Adult | 7 | 2019 | 56430 | 0.140 |
Why?
|
Keratin-18 | 1 | 2016 | 39 | 0.140 |
Why?
|
Myofibromatosis | 1 | 2016 | 30 | 0.140 |
Why?
|
Orbital Pseudotumor | 1 | 2016 | 42 | 0.140 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2015 | 25 | 0.130 |
Why?
|
Muscles | 1 | 2021 | 1614 | 0.130 |
Why?
|
Myofibroma | 1 | 2016 | 50 | 0.130 |
Why?
|
Curettage | 1 | 2015 | 73 | 0.130 |
Why?
|
Head | 1 | 2021 | 880 | 0.130 |
Why?
|
Mucorales | 1 | 2015 | 33 | 0.130 |
Why?
|
Aspergillus | 1 | 2015 | 85 | 0.130 |
Why?
|
Ethmoid Sinus | 1 | 2015 | 58 | 0.130 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19905 | 0.130 |
Why?
|
Vision Disorders | 1 | 2022 | 1058 | 0.130 |
Why?
|
Triamcinolone | 1 | 2015 | 68 | 0.130 |
Why?
|
Nose Diseases | 1 | 2015 | 79 | 0.130 |
Why?
|
Adolescent | 9 | 2022 | 85781 | 0.130 |
Why?
|
Tomography, Optical Coherence | 1 | 2007 | 2657 | 0.130 |
Why?
|
Keratin-14 | 1 | 2014 | 57 | 0.130 |
Why?
|
Atrophy | 1 | 2019 | 1583 | 0.130 |
Why?
|
Lasers, Semiconductor | 1 | 2015 | 46 | 0.130 |
Why?
|
Sphenoid Sinus | 1 | 2015 | 99 | 0.130 |
Why?
|
Headache | 1 | 2022 | 1226 | 0.120 |
Why?
|
Wounds, Nonpenetrating | 2 | 2013 | 794 | 0.120 |
Why?
|
Cadaver | 2 | 2016 | 1337 | 0.120 |
Why?
|
Skin Aging | 1 | 2015 | 127 | 0.120 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 163 | 0.120 |
Why?
|
Hearing Loss | 1 | 2022 | 765 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 547 | 0.120 |
Why?
|
Paranasal Sinus Diseases | 1 | 2015 | 116 | 0.120 |
Why?
|
Disease Progression | 3 | 2019 | 13284 | 0.120 |
Why?
|
Retinal Artery Occlusion | 1 | 2014 | 74 | 0.120 |
Why?
|
Retrobulbar Hemorrhage | 1 | 2013 | 11 | 0.120 |
Why?
|
Rupture, Spontaneous | 1 | 2014 | 354 | 0.120 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2014 | 168 | 0.120 |
Why?
|
Antifungal Agents | 2 | 2015 | 730 | 0.120 |
Why?
|
Calciphylaxis | 1 | 2015 | 124 | 0.120 |
Why?
|
Maxillary Sinus | 1 | 2015 | 180 | 0.120 |
Why?
|
Fever | 1 | 2021 | 1616 | 0.110 |
Why?
|
Amyloidosis | 1 | 2020 | 795 | 0.110 |
Why?
|
Arachnoid | 1 | 2013 | 48 | 0.110 |
Why?
|
Bleomycin | 1 | 2014 | 512 | 0.110 |
Why?
|
Ear | 1 | 2014 | 173 | 0.110 |
Why?
|
Melanocytes | 1 | 2016 | 515 | 0.110 |
Why?
|
Elastin | 1 | 2014 | 308 | 0.110 |
Why?
|
Optic Nerve Glioma | 1 | 2013 | 32 | 0.110 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 654 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2017 | 1850 | 0.110 |
Why?
|
Pneumocephalus | 1 | 2013 | 46 | 0.110 |
Why?
|
Cartilage | 1 | 2016 | 818 | 0.110 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1442 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2021 | 1373 | 0.110 |
Why?
|
Dermis | 1 | 2014 | 207 | 0.110 |
Why?
|
Goblet Cells | 1 | 2015 | 287 | 0.100 |
Why?
|
Antigens, CD20 | 1 | 2012 | 199 | 0.100 |
Why?
|
Recurrence | 1 | 2023 | 8340 | 0.100 |
Why?
|
Acute Disease | 1 | 2022 | 7149 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15540 | 0.100 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2015 | 450 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2023 | 1947 | 0.100 |
Why?
|
Infant | 3 | 2023 | 35136 | 0.100 |
Why?
|
Hemangioma | 1 | 2016 | 738 | 0.100 |
Why?
|
Panniculitis, Lupus Erythematosus | 1 | 2010 | 3 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 692 | 0.090 |
Why?
|
Horns | 1 | 2009 | 9 | 0.090 |
Why?
|
Vision, Binocular | 1 | 2011 | 213 | 0.090 |
Why?
|
Cicatrix | 1 | 2015 | 764 | 0.090 |
Why?
|
Occipital Lobe | 1 | 2011 | 379 | 0.090 |
Why?
|
Platelet Count | 1 | 2012 | 781 | 0.090 |
Why?
|
Optic Nerve | 1 | 2013 | 554 | 0.090 |
Why?
|
Photic Stimulation | 1 | 2016 | 2025 | 0.090 |
Why?
|
Radiotherapy | 1 | 2016 | 1533 | 0.090 |
Why?
|
Osteotomy | 1 | 2015 | 822 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2018 | 6365 | 0.080 |
Why?
|
Demyelinating Diseases | 1 | 2011 | 354 | 0.080 |
Why?
|
Suture Techniques | 1 | 2014 | 798 | 0.080 |
Why?
|
Transplantation, Autologous | 1 | 2014 | 2124 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2012 | 1588 | 0.080 |
Why?
|
Child | 4 | 2023 | 77709 | 0.080 |
Why?
|
Ocular Motility Disorders | 1 | 2009 | 135 | 0.080 |
Why?
|
Eye Movements | 1 | 2011 | 507 | 0.080 |
Why?
|
Chronic Disease | 2 | 2013 | 9146 | 0.080 |
Why?
|
Reference Values | 1 | 2015 | 4982 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3567 | 0.080 |
Why?
|
Neuroglia | 1 | 2013 | 927 | 0.070 |
Why?
|
Facial Paralysis | 1 | 2011 | 338 | 0.070 |
Why?
|
Actins | 1 | 2015 | 2121 | 0.070 |
Why?
|
Visual Pathways | 1 | 2011 | 565 | 0.070 |
Why?
|
Sheep | 1 | 2009 | 1437 | 0.070 |
Why?
|
Corpus Callosum | 1 | 2011 | 737 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4851 | 0.070 |
Why?
|
Intubation | 2 | 2020 | 141 | 0.070 |
Why?
|
Meningioma | 1 | 2014 | 1209 | 0.070 |
Why?
|
Calcinosis | 1 | 2014 | 1499 | 0.070 |
Why?
|
Pilot Projects | 1 | 2019 | 8324 | 0.070 |
Why?
|
Meningeal Neoplasms | 1 | 2014 | 1241 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1378 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9959 | 0.060 |
Why?
|
Vitreous Hemorrhage | 1 | 2005 | 48 | 0.060 |
Why?
|
Diagnostic Imaging | 2 | 2016 | 3507 | 0.060 |
Why?
|
Equipment Design | 1 | 2013 | 3582 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3610 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 3712 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5751 | 0.060 |
Why?
|
Temporal Lobe | 1 | 2011 | 1670 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3749 | 0.060 |
Why?
|
Optic Disk | 1 | 2007 | 400 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2012 | 1580 | 0.060 |
Why?
|
Hospitalization | 1 | 2023 | 10262 | 0.060 |
Why?
|
United States | 4 | 2019 | 69872 | 0.050 |
Why?
|
Intracranial Aneurysm | 1 | 2011 | 1197 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2861 | 0.050 |
Why?
|
Bone Marrow | 1 | 2012 | 2948 | 0.050 |
Why?
|
Eye Evisceration | 1 | 2021 | 23 | 0.050 |
Why?
|
Vitrectomy | 1 | 2005 | 365 | 0.050 |
Why?
|
Eye Enucleation | 1 | 2021 | 128 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 63114 | 0.050 |
Why?
|
Brain Injuries | 1 | 2013 | 2025 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25043 | 0.040 |
Why?
|
Crohn Disease | 1 | 2012 | 2303 | 0.040 |
Why?
|
Prospective Studies | 3 | 2022 | 53288 | 0.040 |
Why?
|
Edema | 1 | 2022 | 789 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 294 | 0.040 |
Why?
|
Melanoma | 1 | 2015 | 5510 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1107 | 0.030 |
Why?
|
Rhizopus | 1 | 2015 | 21 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10638 | 0.030 |
Why?
|
Nasal Cavity | 1 | 2016 | 313 | 0.030 |
Why?
|
Sclerotherapy | 1 | 2014 | 175 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2035 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1970 | 0.030 |
Why?
|
Risk Factors | 3 | 2015 | 72290 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 2015 | 389 | 0.030 |
Why?
|
Blood Sedimentation | 1 | 2012 | 231 | 0.030 |
Why?
|
Mycoses | 1 | 2014 | 376 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40075 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1060 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2252 | 0.020 |
Why?
|
Nasal Mucosa | 1 | 2012 | 373 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1574 | 0.020 |
Why?
|
Shaken Baby Syndrome | 1 | 2005 | 23 | 0.020 |
Why?
|
Graft Survival | 1 | 2015 | 3737 | 0.020 |
Why?
|
Wound Healing | 1 | 2015 | 2785 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2002 | 0.020 |
Why?
|
Colonoscopy | 1 | 2012 | 1367 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 7023 | 0.010 |
Why?
|
Birth Injuries | 1 | 2005 | 148 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2015 | 3297 | 0.010 |
Why?
|
Health Surveys | 1 | 2013 | 4037 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4149 | 0.010 |
Why?
|
Animals | 4 | 2016 | 168757 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4042 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2016 | 25625 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4251 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9849 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1179 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 29144 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 21746 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20947 | 0.010 |
Why?
|
Child, Preschool | 1 | 2010 | 41006 | 0.000 |
Why?
|